1. Mutations in respiratory complex I promote antibiotic persistence through alterations in intracellular acidity and protein synthesis.
- Author
-
Van den Bergh B, Schramke H, Michiels JE, Kimkes TEP, Radzikowski JL, Schimpf J, Vedelaar SR, Burschel S, Dewachter L, Lončar N, Schmidt A, Meijer T, Fauvart M, Friedrich T, Michiels J, and Heinemann M
- Subjects
- Bacteria genetics, Bacterial Proteins, Escherichia coli genetics, Escherichia coli metabolism, Evolution, Molecular, Ion Channels, Liposomes, Microbial Sensitivity Tests, Protein Domains, Proteomics, Regulon drug effects, Sigma Factor metabolism, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial drug effects, Electron Transport Complex I genetics, Electron Transport Complex I metabolism, Mutation, Protein Biosynthesis drug effects
- Abstract
Antibiotic persistence describes the presence of phenotypic variants within an isogenic bacterial population that are transiently tolerant to antibiotic treatment. Perturbations of metabolic homeostasis can promote antibiotic persistence, but the precise mechanisms are not well understood. Here, we use laboratory evolution, population-wide sequencing and biochemical characterizations to identify mutations in respiratory complex I and discover how they promote persistence in Escherichia coli. We show that persistence-inducing perturbations of metabolic homeostasis are associated with cytoplasmic acidification. Such cytoplasmic acidification is further strengthened by compromised proton pumping in the complex I mutants. While RpoS regulon activation induces persistence in the wild type, the aggravated cytoplasmic acidification in the complex I mutants leads to increased persistence via global shutdown of protein synthesis. Thus, we propose that cytoplasmic acidification, amplified by a compromised complex I, can act as a signaling hub for perturbed metabolic homeostasis in antibiotic persisters., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF